benzbromarone has been researched along with Dyslipidemias in 1 studies
Benzbromarone: Uricosuric that acts by increasing uric acid clearance. It is used in the treatment of gout.
benzbromarone : 1-Benzofuran substituted at C-2 and C-3 by an ethyl group and a 3,5-dibromo-4-hydroxybenzoyl group respectively. An inhibitor of CYP2C9, it is used as an anti-gout medication.
Dyslipidemias: Abnormalities in the serum levels of LIPIDS, including overproduction or deficiency. Abnormal serum lipid profiles may include high total CHOLESTEROL, high TRIGLYCERIDES, low HIGH DENSITY LIPOPROTEIN CHOLESTEROL, and elevated LOW DENSITY LIPOPROTEIN CHOLESTEROL.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Therefore, 35." | 1.51 | Nephrolithiasis in gout: prevalence and characteristics of Brazilian patients. ( Fuller, R; Goldenstein-Schainberg, C; Hoff, LS, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hoff, LS | 1 |
| Goldenstein-Schainberg, C | 1 |
| Fuller, R | 1 |
1 other study available for benzbromarone and Dyslipidemias
| Article | Year |
|---|---|
Nephrolithiasis in gout: prevalence and characteristics of Brazilian patients.
Topics: Adult; Asymptomatic Diseases; Benzbromarone; Brazil; Cross-Sectional Studies; Diabetes Mellitus; Diu | 2019 |